Markus H. Moehler
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 235 publications
Adenocarcinomas of the Gastroesophageal Junction and Stomach: Current Management
Journal: Deutsche medizinische Wochenschrift (1946)
Published: September 07, 2026
Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer.
Journal: Cancer biomarkers : section A of Disease markers
Published: August 21, 2026
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 23, 2026
Analysis of colorectal liver metastases in photon-counting detector CT - optimizing imaging through spectral reconstruction.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: February 11, 2026
European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 study.
Journal: EClinicalMedicine
Published: January 22, 2026
Temporal trends and risk factors of extracranial major bleeding in patients with acute pulmonary embolism.
Journal: Thrombosis research
Published: December 07, 2025
PROMs: Patient related or patient centred? A bridge between Patient-Reported Outcome Measures (PROMs) and clinical ethics in the context of a cohort of gynaeco-oncological patients analysed by qualitative semi- structured interviews.
Journal: Journal of patient-reported outcomes
Published: October 19, 2025
Gastric Carcinoma: Diagnosis, Staging, and Treatment.
Journal: Deutsches Arzteblatt international
Published: October 14, 2025
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 24, 2025
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 13, 2025
Last Updated: 09/26/2026